Cargando…

Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management

BACKGROUND: Regorafenib is an orally available, small-molecule multikinase inhibitor with international marketing authorizations for use in colorectal cancer and gastrointestinal stromal tumors. In clinical trials, regorafenib showed a consistent and predictable adverse-event profile, with hand–foot...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLellan, B., Ciardiello, F., Lacouture, M. E., Segaert, S., Van Cutsem, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576906/ https://www.ncbi.nlm.nih.gov/pubmed/26034039 http://dx.doi.org/10.1093/annonc/mdv244

Ejemplares similares

Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands
por: Nonomiya, Yuma, et al.
Publicado: (2019)

Efficacy of compound traditional Chinese medicine oil in alleviating regorafenib-induced hand-foot skin reaction
por: Zhang, Liyan, et al.
Publicado: (2021)

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial
por: Nishizawa, Aya, et al.
Publicado: (2023)

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
por: Dranitsaris, G., et al.
Publicado: (2012)

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
por: Melosky, Barbara L., et al.
Publicado: (2018)

Grade III hand-foot skin reaction induced by sorafenib
por: Chiriac, Anca, et al.
Publicado: (2017)

Sorafenib Induced Hand-Foot Skin Reaction at Low Dose
por: Shah, Vrutika H., et al.
Publicado: (2020)

Surgical and Practical Observations on the Diseases of the Human Foot, with Instructions for Their Treatment. To Which Is Added Advice on the Management of the Hand
Publicado: (1845)

Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer
por: Xia, Hui, et al.
Publicado: (2021)

Hand-Foot Skin Reaction with Sunitinib: A Rare Case Report with Review of Literature
por: Das, Suchibrata, et al.
Publicado: (2020)

Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment
por: Ochi, Masanori, et al.
Publicado: (2021)

Critical appraisal of the use of regorafenib in the management of colorectal cancer
por: Festino, Lucia, et al.
Publicado: (2013)

Prevention and management of adverse events related to regorafenib
por: De Wit, Mieke, et al.
Publicado: (2013)

Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib
por: Otsuka, Haruhiko, et al.
Publicado: (2022)

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib
por: Jain, Lokesh, et al.
Publicado: (2010)

Clinical activity of regorafenib in elderly patients with recurrent glioblastoma
por: Fasano, Morena, et al.
Publicado: (2023)

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
por: Hofheinz, R-D, et al.
Publicado: (2012)

A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system
por: Coolbrandt, A., et al.
Publicado: (2023)

Practical considerations in the use of regorafenib in metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2020)

Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K)
por: Nam, Se Hyun, et al.
Publicado: (2016)

The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand–Foot Skin Reaction
por: Shou, Liumei, et al.
Publicado: (2021)

Regorafenib prevents the development of emphysema in a murine elastase model
por: Oh, Kwangseok, et al.
Publicado: (2023)

A case report for severe hand-foot skin reaction caused by chemotherapy with actinomycin D in a patient with oculocutaneous albinism
por: Yan, Shi-Jie, et al.
Publicado: (2019)

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
por: Wang, Enxin, et al.
Publicado: (2019)

Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)
por: Lambert, J.L.W., et al.
Publicado: (2020)

Effectiveness of school-based smoking prevention curricula: systematic review and meta-analysis
por: Thomas, Roger E, et al.
Publicado: (2015)

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
por: Ramaswamy, Anant, et al.
Publicado: (2019)

Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice
por: Wang, Wan, et al.
Publicado: (2019)

Allergens in Hand, Foot, and Hand–Foot Eczema: An Intercomparison by Patch Testing
por: Sahana, S, et al.
Publicado: (2021)

Principles and practical applications of structure-based vaccine design
por: Byrne, Patrick O, et al.
Publicado: (2022)

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
por: Yoon, Sang Eun, et al.
Publicado: (2018)

Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review
por: Pirozzi, Mario, et al.
Publicado: (2022)

Concurrent Hand-Foot Skin Reaction and Hair Depigmentation With Sunitinib: Report of a Case and Literature Review of Kinase Inhibitors and Blocking Antibodies
por: Bansal, Shuchi, et al.
Publicado: (2014)

Hand Foot Syndrome Has the Strongest Impact on QOL in Skin Toxicities of Chemotherapy
por: Urakawa, Ryuta, et al.
Publicado: (2019)

Erythema multiforme induced by regorafenib
por: Matsunaga, Mototsugu, et al.
Publicado: (2017)

Estrogen-deficient skin: The role of topical therapy()()
por: Rzepecki, Alexandra K., et al.
Publicado: (2019)

Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
por: Fu, Qiang, et al.
Publicado: (2019)

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer
por: Punt, C.J.A., et al.
Publicado: (2023)

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
por: Belli, Valentina, et al.
Publicado: (2017)

A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
por: Weiskirchen, Sabine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l3qgkvfi0l1v6ipkpjua63aetu